Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -138,626 | -97,765 | -52,764 | -69,612 | -26,746 |
| Depreciation Amortization | 3,420 | 788 | 350 | 1,158 | 833 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 7,989 |
| Accounts receivable | -2,303 | -1,705 | N/A | -1,250 | N/A |
| Accounts payable and accrued liabilities | -14,169 | -1,600 | -53 | 18,312 | 5,392 |
| Other Working Capital | -19,608 | -5,128 | -5,764 | 1,897 | -3,550 |
| Other Operating Activity | 31,858 | 12,969 | 4,599 | -96,508 | -89,449 |
| Operating Cash Flow | $-139,428 | $-92,441 | $-53,632 | $-146,003 | $-105,531 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 73,086 | 112,688 | 72,649 | -163,725 | -164,041 |
| PPE Investments | -282 | -187 | -127 | -434 | -366 |
| Purchase Sale Intangibles | -4,000 | -4,000 | N/A | 2,000 | -5,000 |
| Other Investing Activity | -4,000 | -4,000 | 0 | 102,000 | 95,000 |
| Investing Cash Flow | $68,804 | $108,501 | $72,522 | $-62,159 | $-69,407 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 75,000 | 37,500 | N/A | N/A | 0 |
| Common Stock Issued | 121,463 | 399 | 399 | 166,481 | 166,381 |
| Financing Cash Flow | $196,463 | $37,899 | $399 | $166,481 | $166,381 |
| Beginning Cash Position | 59,576 | 59,576 | 59,576 | 101,257 | 101,257 |
| End Cash Position | 185,415 | 113,535 | 78,865 | 59,576 | 92,700 |
| Net Cash Flow | $125,839 | $53,959 | $19,289 | $-41,681 | $-8,557 |
| Free Cash Flow | |||||
| Operating Cash Flow | -139,428 | -92,441 | -53,632 | -146,003 | -105,531 |
| Capital Expenditure | -282 | -187 | -127 | -434 | -366 |
| Free Cash Flow | -139,710 | -92,628 | -53,759 | -146,437 | -105,897 |